Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis

NCT02845934 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT02845934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02845934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2014
Completion date
January 31, 2018
Enrollment
248 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

mucormycosis